Remove Disease Remove Nurses Remove Trials Remove Virus
article thumbnail

NHS staff sign up to Covid-19 sniffer dog trial

The Pharma Data

NHS staff are taking part in a trial to see if dogs can sniff out Covid-19 – even in people who are asymptomatic. If the trial is successful, the dogs could be used at UK airports to screen people arriving from abroad. If the trial is successful, the dogs could be used at UK airports to screen people arriving from abroad.

Trials 52
article thumbnail

Deliberate Dysentery

Codon

Today, refined versions of these human challenge studies have become standard practice in testing vaccines for vector-borne diseases (e.g., yellow fever, malaria, and dengue), evaluating new drugs or treatments, and studying pathogenesis, the process by which a disease develops. Why are challenge trials becoming more popular?

Vaccine 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Regeneron Announces Encouraging Initial Data from COVID-19 Antibody Cocktail Trial in Hospitalized Patients on Low-flow Oxygen

The Pharma Data

As in earlier outpatient trial, immune status when patients entered the trial was a strong predictor of viral load and clinical outcomes. The primary clinical objective of this initial analysis was to determine if there was sufficient efficacy in these patients to warrant continuing the trial (i.e., futility analysis).

article thumbnail

FDA Approves Emergency Use of Pfizer’s COVID Vaccine

The Pharma Data

. “The tireless work to develop a new vaccine to prevent this novel, serious and life-threatening disease in an expedited timeframe after its emergence is a true testament to scientific innovation and public-private collaboration worldwide.” Centers for Disease Control and Prevention advisory panel.

Vaccine 52
article thumbnail

U.S. Rollout of Pfizer COVID Vaccine Begins

The Pharma Data

Residents of nursing homes, who have suffered a disproportionate share of COVID-19 deaths, will begin to get shots next week, the Times reported. ” The nursing home industry applauded the approval. The association represents 14,000 nursing homes and assisted living facilities.

Vaccine 52
article thumbnail

Pfizer-BioNTech Vaccine Receives Emergency Use Authorization

The Pharma Data

Food and Drug Administration issued the EUA for use of the vaccine in individuals ages 16 years and older late Friday evening, allowing a national vaccine campaign against the virus to begin this week. Centers for Disease Control and Prevention Director Robert R. Redfield, M.D., The EUA was issued to Pfizer. More Information.

Vaccine 52
article thumbnail

Regeneron Announces U.S. Government Agreement to Purchase Additional COVID-19 Antibody Cocktail Doses

The Pharma Data

“Patients in our antibody cocktail outpatient clinical trial experienced significant reductions in virus levels and required fewer medical visits for COVID-19, suggesting the therapy can help reduce the current burden on hospitals and healthcare systems,” said George D. . Have chronic kidney disease. Have diabetes.